[HTML][HTML] Remembrance of things past: long-term B cell memory after infection and vaccination

AKE Palm, C Henry - Frontiers in immunology, 2019 - frontiersin.org
The success of vaccines is dependent on the generation and maintenance of immunological
memory. The immune system can remember previously encountered pathogens, and …

Aging and influenza vaccine-induced immunity

HL Dugan, C Henry, PC Wilson - Cellular immunology, 2020 - Elsevier
Immunosenescence is defined as the progressive deterioration of the immune system with
aging. Immunosenescence stifles the generation of protective B and T cell-mediated …

[HTML][HTML] Review of COVID-19 vaccines and their evidence in older adults

SP Teo - Annals of geriatric medicine and research, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has resulted in a global pandemic and significant …

Comparative immunogenicity of several enhanced influenza vaccine options for older adults: a randomized, controlled trial

BJ Cowling, RAPM Perera… - Clinical Infectious …, 2020 - academic.oup.com
Background Enhanced influenza vaccines may improve protection for older adults, but
comparative immunogenicity data are limited. Our objective was to examine immune …

[HTML][HTML] Aging and options to halt declining immunity to virus infections

MÁ Palacios-Pedrero, ADME Osterhaus… - Frontiers in …, 2021 - frontiersin.org
Immunosenescence is a process associated with aging that leads to dysregulation of cells of
innate and adaptive immunity, which may become dysfunctional. Consequently, older adults …

[HTML][HTML] Immunosenescence and altered vaccine efficiency in older subjects: A myth difficult to change

T Fulop, A Larbi, G Pawelec, AA Cohen, G Provost… - Vaccines, 2022 - mdpi.com
Organismal ageing is associated with many physiological changes, including differences in
the immune system of most animals. These differences are often considered to be a key …

Influenza vaccines: successes and continuing challenges

T Becker, H Elbahesh, LA Reperant… - The Journal of …, 2021 - academic.oup.com
Influenza vaccines have been available for over 80 years. They have contributed to
significant reductions in influenza morbidity and mortality. However, there have been …

[HTML][HTML] Who and when to vaccinate against influenza

P Buchy, S Badur - International Journal of Infectious Diseases, 2020 - Elsevier
Known since Hippocrates and of continuing public health importance, influenza remains a
major cause of morbidity and mortality worldwide, and large segments of the human …

Vaccines for older adults

AL Cunningham, P McIntyre, K Subbarao, R Booy… - bmj, 2021 - bmj.com
The proportion of the global population aged 65 and older is rapidly increasing. Infections in
this age group, most recently with SARS-CoV-2, cause substantial morbidity and mortality …

[HTML][HTML] Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical …

AH Forster, K Witham, ACI Depelsenaire… - PLoS …, 2020 - journals.plos.org
Background The Vaxxas high-density microarray patch (HD-MAP) consists of a high density
of microprojections coated with vaccine for delivery into the skin. Microarray patches (MAPs) …